In recent years, omics is a rapidly evolving bioanalytical technology that is a powerful research tool for studying the pathogenesis of cardiovascular disease. Ace Therapeutics provides multi-omics services to aggressively advance the study of cardiovascular disease pathogenesis and the development of diagnostic and therapeutic strategies.
In the last decade, omics technologies, including genomics, transcriptomics, proteomics and metabolomics, have developed rapidly and become an integrated science and technology for studying different levels and dimensions of biology. Undoubtedly, in the field of cardiovascular disease research, omics technology has gradually become an important tool for studying the pathogenesis and pharmacological mechanisms of various cardiovascular diseases, and has been widely used in the discovery of cardiovascular biomarkers and signaling pathway research.
Fig. 1 Downstream effects of microbe-derived metabolites and their roles in CVDs. (Xu J, and Yang Y, 2021)
Ace Therapeutics strives to provide cardiovascular disease researchers with comprehensive and high-quality muti-omics solutions, and is committed to helping you solve difficulties encountered in cardiovascular disease research.
We can provide our clients with genomics analysis services to help reveal the gene function and genetic regulatory mechanisms of various cardiovascular diseases.
We can provide professional transcriptomics testing and analysis services to help explore microRNA biomarkers and identify signaling pathways related to cardiovascular disease.
We are committed to providing proteomics research services to our clients to clarify the functions and regulatory mechanisms of proteins in cardiovascular diseases by analyzing their expression and interactions.
We can provide our clients with metabolomics research services to study changes in metabolic states and metabolic pathways associated with cardiovascular disease.
Ace Therapeutics is a contract research organization specializing in cardiovascular disease research. We strive to provide high-quality omics research solutions for researchers to promote new breakthroughs and advances in research into cardiovascular disease. If you are interested in our omics services for cardiovascular diseases, please do not hesitate to contact us.
Copyright © Ace Therapeutics. All rights reserved.